Percutaneous caffeine application in the treatment of neonatal apnoea.
about
Performance of transdermal therapeutic systems: Effects of biological factorsGlucose monitoring in neonates: need for accurate and non-invasive methods.Release and permeation kinetics of caffeine from bioadhesive transdermal films.Drug silica nanocomposite: preparation, characterization and skin permeation studies.Caffeine-loaded niosomes: characterization and in vitro release studies.
P2860
Percutaneous caffeine application in the treatment of neonatal apnoea.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Percutaneous caffeine application in the treatment of neonatal apnoea.
@en
Percutaneous caffeine application in the treatment of neonatal apnoea.
@nl
type
label
Percutaneous caffeine application in the treatment of neonatal apnoea.
@en
Percutaneous caffeine application in the treatment of neonatal apnoea.
@nl
prefLabel
Percutaneous caffeine application in the treatment of neonatal apnoea.
@en
Percutaneous caffeine application in the treatment of neonatal apnoea.
@nl
P356
P1476
Percutaneous caffeine application in the treatment of neonatal apnoea
@en
P2093
P2888
P304
P356
10.1007/BF02072214
P577
1991-06-01T00:00:00Z
P6179
1012844711